Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9958)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2020 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang FP, Huang YP, Luo WX, Deng WY, Liu CQ, Xu LB, Liu C. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment. World J Gastroenterol 2020; 26(2): 134-153 [PMID: 31969776 DOI: 10.3748/wjg.v26.i2.134] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6190/full/v26/i2/134.htm |
| Number | Citing Articles |
| 1 |
Shitao Jiang, Junwei Zhang, Jin Bian, Lei Zhang, Yiyao Xu, Haitao Zhao, Xinting Sang, Xin Lu. Novel nomograms based on immune and stromal scores for predicting the disease‐free and overall survival of patients with hepatocellular carcinoma undergoing radical surgery. Journal of Surgical Oncology 2020; 122(8): 1569 doi: 10.1002/jso.26197
|
| 2 |
Bangmin Wang, Xin Wang, Xinhui Du, Shilei Gao, Bo Liang, Weitao Yao. Identification and prognostic evaluation of differentially expressed long noncoding RNAs associated with immune infiltration in osteosarcoma. Heliyon 2024; 10(5): e27023 doi: 10.1016/j.heliyon.2024.e27023
|
| 3 |
Xiqin Wang, Chenguang Ji. Construction of a prognostic risk model based on apoptosis-related genes to assess tumor immune microenvironment and predict prognosis in hepatocellular carcinoma. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02481-w
|
| 4 |
Shixin Xiang, Jing Li, Jing Shen, Yueshui Zhao, Xu Wu, Mingxing Li, Xiao Yang, Parham Jabbarzadeh Kaboli, Fukuan Du, Yuan Zheng, Qinglian Wen, Chi Hin Cho, Tao Yi, Zhangang Xiao. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.653836
|
| 5 |
Si-Yuan Lu, Jie Hua, Jiang Liu, Miao-Yan Wei, Chen Liang, Qing-Cai Meng, Bo Zhang, Xian Jun Yu, Wei Wang, Jin Xu. Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01371-0
|
| 6 |
Hehua Ma, Yuxin Hong, Zhenzhen Xu, Zuyi Weng, Yuanxun Yang, Dandan Jin, Zhiyou Chen, Jing Yue, Xuan Zhou, Zhi Xu, Fei Fei, Juan Li, Wei Song. N6-methyladenosine (m6A) modification in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2024; 173: 116365 doi: 10.1016/j.biopha.2024.116365
|
| 7 |
Shanshan Yu, Luya Cai, Chuan Liu, Ruihong Gu, Lingyi Cai, Leying Zhuo. Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma. Molecular Medicine 2021; 27(1) doi: 10.1186/s10020-021-00294-3
|
| 8 |
Bo Gao, Vipin Balyan. Construction of a financial default risk prediction model based on the LightGBM algorithm. Journal of Intelligent Systems 2022; 31(1): 767 doi: 10.1515/jisys-2022-0036
|
| 9 |
Xiaoyong Li, Jiaqong Lin, Yuguo pan, Peng Cui, Jintang Xia. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2021; 20: 153303382110414 doi: 10.1177/15330338211041425
|
| 10 |
Cong Lu, Dong Hu, Jin’e Zheng, Shiyi Cao, Jiang Zhu, Xiangjun Chen, Shiang Huang, Junxia Yao, Yingkun Xu. A Six-Gene Risk Model Based on the Immune Score Reveals Prognosis in Intermediate-Risk Acute Myeloid Leukemia. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4010786
|
| 11 |
Yang Shu, Lingling He, Meixin Gao, Fan Xiao, Junru Yang, Shiwei Wang, Herui Wei, Fuyang Zhang, Hongshan Wei. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma. Frontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.780509
|
| 12 |
Kunfu Dai, Chao Liu, Ge Guan, Jinzhen Cai, Liqun Wu. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09587-0
|
| 13 |
Cuiju Wang, Yalei Lv, Ziyue Sha, Jingjing Zhang, Jianhua Wu, Yixin Qi, Zhanjun Guo. Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway. Journal of Hepatocellular Carcinoma 2021; : 1643 doi: 10.2147/JHC.S327258
|
| 14 |
Zhihuai Wang, Adeel Ur Rehman, Xihu Qin, Chunfu Zhu, Siyuan Wu, Ihtisham Bukhari. PI3K/AKT/mTOR Pathway-Associated Genes Reveal a Putative Prognostic Signature Correlated with Immune Infiltration in Hepatocellular Carcinoma. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/7545666
|
| 15 |
Enjiang Lai, Yang Tai, Jingsun Jiang, Chong Zhao, Yang Xiao, Xin Quan, Hao Wu, Jinhang Gao. Prognostic evaluation and immune infiltration analysis of five bioinformatic selected genes in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2021; 25(24): 11128 doi: 10.1111/jcmm.17035
|
| 16 |
Jonathan Melendez-Torres, Amit G. Singal. Early detection of hepatocellular carcinoma: roadmap for improvement. Expert Review of Anticancer Therapy 2022; 22(6): 621 doi: 10.1080/14737140.2022.2074404
|
| 17 |
Lihua Yu, Xiaoli Liu, Xinhui Wang, Huiwen Yan, Qing Pu, Yuqing Xie, Juan Du, Zhiyun Yang. Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.940551
|
| 18 |
Ya Guo, Ya Li Wang, Wang Hui Su, Peng Tao Yang, Jing Chen, Heng Luo. Three Genes Predict Prognosis in Microenvironment of Ovarian Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00990
|
| 19 |
Weiwei Cao, Yu Chen, Wei Han, Juzheng Yuan, Weimin Xie, Kun Liu, Yan Qiu, Xudan Wang, Xiao Li. Potentiality of α-fetoprotein (AFP) and soluble intercellular adhesion molecule-1 (sICAM-1) in prognosis prediction and immunotherapy response for patients with hepatocellular carcinoma. Bioengineered 2021; 12(2): 9435 doi: 10.1080/21655979.2021.1990195
|
| 20 |
Jianhua Wu, Xueting Ren, Nan Wang, Ruina Zhou, Mengsha Chen, Yifan Cai, Shuai Lin, Hao Zhang, Xin Xie, Chengxue Dang, Shuqun Zhang, Zhangjian Zhou. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.779554
|
| 21 |
Tao Ouyang, Xuefeng Kan, Chuansheng Zheng. Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.898964
|
| 22 |
Yifei Dai, Weijie Qiang, Kequan Lin, Yu Gui, Xun Lan, Dong Wang. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma. Cancer Immunology, Immunotherapy 2021; 70(4): 967 doi: 10.1007/s00262-020-02743-0
|
| 23 |
Claudia Ollauri-Ibáñez, Blanca Ayuso-Íñigo, Miguel Pericacho. Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?. Cancers 2021; 13(7): 1552 doi: 10.3390/cancers13071552
|
| 24 |
Zhuomao Mo, Shuqiao Zhang, Shijun Zhang. A Novel Signature Based on mTORC1 Pathway in Hepatocellular Carcinoma. Journal of Oncology 2020; 2020: 1 doi: 10.1155/2020/8291036
|
| 25 |
Renjie Liu, Guifu Wang, Chi Zhang, Dousheng Bai. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02175-9
|
| 26 |
Jun Liu, Jianjun Lu, Wenli Li, Wenjie Mao, Yamin Lu. Machine Learning Screens Potential Drugs Targeting a Prognostic Gene Signature Associated With Proliferation in Hepatocellular Carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.900380
|
| 27 |
Qingxin Shi, Jiangcheng He, Guangya Chen, Jinlin Xu, Zhaoxiang Zeng, Xueyan Zhao, Binbin Zhao, Xiang Gao, Zhihua Ye, Mingzhong Xiao, Hanmin Li. The chemical composition of Diwu YangGan capsule and its potential inhibitory roles on hepatocellular carcinoma by microarray-based transcriptomics. Journal of Traditional and Complementary Medicine 2023; doi: 10.1016/j.jtcme.2023.12.002
|
| 28 |
Xiaolong Tang, Yandong Miao, Lixia Yang, Wuhua Ha, Zheng Li, Denghai Mi. Single‐cell RNA‐seq and bulk RNA‐seq explore the prognostic value of exhausted T cells in hepatocellular carcinoma. IET Systems Biology 2023; 17(4): 228 doi: 10.1049/syb2.12072
|
| 29 |
Deming Ou, Ying Wu. The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-09058-y
|
| 30 |
Wei Zhang, Kegong Chen, Wei Tian, Qi Zhang, Lin Sun, Yupeng Wang, Meina Liu, Qiuju Zhang. A Novel and Robust Prognostic Model for Hepatocellular Carcinoma Based on Enhancer RNAs-Regulated Genes. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.849242
|